Drug Abuse Testing Companies

AstraZeneca acquires ADC Therapeutics: This $5.2 billion deal strengthens AstraZeneca's oncology pipeline, specifically expanding its presence in antibody-drug conjugates (ADCs) used in immunotherapy.

Pfizer returns Bavencio rights to Merck KGaA: While this shake-up might seem surprising, it allows Pfizer to focus on its core oncology portfolio and gain royalties on future Bavencio sales

Merck's Keytruda expands reach: New FDA approvals for treating non-small cell lung cancer and cervical cancer solidify Keytruda's dominance in the market.

Bristol Myers Squibb's Opdivo scores big: Opdivo, another leading checkpoint inhibitor, receives FDA approval for a new combination therapy in advanced bladder cancer

Incyte and Macrogenics report promising early-stage clinical trial results for novel immunotherapy targets, showing potential for future disruptions

• Abbott Laboratories


• Quest Diagnostics Incorporated


• Express Diagnostics


• Thermo Fisher Scientific Inc.


• Siemens AG


• Pfizer


• Dragerwerk AG & Co. KGAA


• OraSure


• Hoffmann-La Roche AG


• Premier Biotech


• Alfa Scientific Designs


• MPD


• SureHire


• Lifeloc


• Omega Laboratories


• CannAmm


• Shimadzu


• Psychemedics


• Laboratory Corporation of America Holdings (LabCorp)


• Randox Laboratories


• Sonic Healthcare


• Bio-Rad Laboratories